Novel Bone Regeneration Drug Osteogrow: Therapeutic Solution for Lumbar Back Pain

Project Information

OSTEOproSPINE

Grant agreement ID: 779340

DOI

10.3030/779340

Project closed

EC signature date 21 November 2017

Start date 1 January 2018

End date 30 June 2023

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost

€ 6 004 152,50

EU contribution

€ 6 004 152,50

Coordinated by

SVEUCILISTE U ZAGREBU MEDICINSKI FAKULTET
Croatia